This milestone represents a meaningful shift in Novo Nordisk recently received FDA approval to bring its oral semaglutide formulation, Rybelsus, under the Ozempic brand aligning oral and injectable semaglutide for type 2 diabetes under a single, highly recognized name On February 24, 2026, Novo Nordisk announced it will significantly reduce the wholesale acquisition cost (WAC) of several of its GLP1 therapies, effective January 1, 2027 On February 20, 2026 the U.S
Avoid direct sunlight If the contents accidentally get into your eyes, please rinse with running water immediately
General Tips for These Early Weeks Listen to your body : Track your cravings, energy, hydration, and mood
However, there is research suggesting that combined contraceptives (like the pill) can become less effective if used at the same time as an anti-fungal medication called griseofulvin [4]